Innovations in heart valve treatments through TAVR/TAVI technology July 13, 2020 Overview Show transcript Overview Mayo Clinic heart specialists at the Rochester, Minnesota, campus review advances in the treatment of aortic valve disease, including new options for treatment with transcatheter aortic valve replacement (TAVR) and transcatheter aortic valve implantation (TAVI). Hector I. Michelena, M.D., cardiologist, and Arman Arghami, M.D., and Phillip G. Rowse, M.D., cardiovascular surgeons, also discuss complex conditions involving redo or repeat operations or multiple valve interventions. Explore more Mayo Clinic Cardiovascular Medicine Resources for medical professionals. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleInnovative TAVR heart valve treatments benefit more patients VID-20491957 Medical Professionals Innovations in heart valve treatments through TAVR/TAVI technology